169 results
8-K
INVA
Innoviva Inc
29 Apr 24
Departure of Directors or Certain Officers
6:14pm
, to the extent then-unvested, will immediately vest in full upon a termination of Mr. Small’s service due to his death or disability or upon a change in control
8-K
EX-99.1
INVA
Innoviva Inc
6 Nov 23
Regulation FD Disclosure
8:30am
(18.9) 76 (24.7) SAEs 0 0 Drug - related SAEs 0 0 Withdrawals due to adverse events 0 0 TEAEs leading to death 0 0 TEAE Zoliflodacin CRO - AZI Headache
8-K
cn10jp
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-10.1
4p8qetr8nd
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
SC TO-T
EX-99
kok5wmi92lh1ex
25 Jul 22
Third party tender offer statement
8:34am
SC TO-C
EX-2.1
remh61vi5mjlne83jbt
11 Jul 22
Information about tender offer
3:46pm
SC TO-C
EX-10.1
c7aps efv7jgnes
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
g5zst7zxf cr
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
8-K
EX-10.1
tzyf9
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
q65j52l
11 Jul 22
Business combination disclosure
7:38am
SC TO-T
EX-99
00epwu bhyd1pi9
7 Jun 22
Third party tender offer statement
9:04am
SC TO-T
EX-99
rab1wu8feuwc3
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-2.1
r3hw5y1u50faekdg ik
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
znoud95v37 3fv1
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.1
10mm1roq f75h
2 May 22
Departure of Directors or Certain Officers
5:27pm
8-K
44a454hr3mbma4x
2 May 22
Departure of Directors or Certain Officers
5:27pm